Search

Your search keyword '"Visser LE"' showing total 17 results

Search Constraints

Start Over You searched for: Author "Visser LE" Remove constraint Author: "Visser LE" Topic anticoagulants Remove constraint Topic: anticoagulants
17 results on '"Visser LE"'

Search Results

1. Body weight is negatively associated with direct oral anticoagulant trough concentrations in dabigatran and apixaban users.

2. Overanticoagulation is associated with renal function decline.

3. Validation of the acenocoumarol EU-PACT algorithms: similar performance in the Rotterdam Study cohort as in the original study.

4. Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users.

5. Selective serotonin re-uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatment.

6. Proton pump inhibitors and the risk of overanticoagulation during acenocoumarol maintenance treatment.

7. A genome-wide association study of acenocoumarol maintenance dosage.

8. Genotypes associated with reduced activity of VKORC1 and CYP2C9 and their modification of acenocoumarol anticoagulation during the initial treatment period.

9. CYP2C9 genotyping in acenocoumarol treatment: is it a cost-effective addition to international normalized ratio monitoring?

10. Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulants.

11. Patients with an ApoE epsilon4 allele require lower doses of coumarin anticoagulants.

12. The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants.

13. The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon.

14. Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumon.

15. The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon.

16. Overanticoagulation associated with combined use of antibacterial drugs and acenocoumarol or phenprocoumon anticoagulants.

17. Overanticoagulation associated with combined use of antifungal agents and coumarin anticoagulants.

Catalog

Books, media, physical & digital resources